Combining commercial production of multi-products in a GMP environment with Clinical & R&D activities

Mono-product facilities are turning to multi-product to cope with decreasing prices of [¹⁸F]-FDG (FDG) and to support R&D programs. The aim is to demonstrate that in the same facility and equipment, a busy research program can be safely integrated into commercial production.

Cristiana Gameiro, Ian Oxley, Antero Abrunhosa, Vasko Kramer, Maria Vosjan, Arnold Spaans